Provided by Tiger Fintech (Singapore) Pte. Ltd.

Emergent BioSolutions

5.60
-0.1700-2.95%
Volume:689.10K
Turnover:3.87M
Market Cap:303.43M
PE:-1.56
High:5.79
Open:5.58
Low:5.46
Close:5.77
Loading ...

CORRECTED-India's Syngene International acquires first US biologics facility for $36.5 mln

Reuters
·
Yesterday

Emergent to Sell Baltimore-Bayview Facility for $36.5 Million

MT Newswires Live
·
Yesterday

Emergent BioSolutions Inc - to Sell Baltimore-Bayview Facility for $36.5 Million

THOMSON REUTERS
·
Yesterday

Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International

THOMSON REUTERS
·
Yesterday

Press Release: Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International

Dow Jones
·
Yesterday

Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio

Zacks
·
06 Mar

Emergent BioSolutions Inc. (NYSE:EBS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Simply Wall St.
·
06 Mar

Is Emergent BioSolutions (NYSE:EBS) Weighed On By Its Debt Load?

Simply Wall St.
·
06 Mar

Emergent BioSolutions’ Earnings Call: Balancing Achievements and Challenges

TIPRANKS
·
05 Mar

Emergent BioSolutions falls -16.0%

TIPRANKS
·
04 Mar

Emergent BioSolutions Shares Down 14.2% After Quarterly Revenue Falls

THOMSON REUTERS
·
04 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Wellgistics, Capricor, Wave Life Sciences

Reuters
·
04 Mar

Emergent Biosolutions Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
04 Mar

Emergent BioSolutions Shares Down 13.6% Premarket After Quarterly Revenue Falls

THOMSON REUTERS
·
04 Mar

Emergent BioSolutions (EBS) Q4 2024 Earnings Call Transcript

Motley Fool Transcribing
·
04 Mar

Emergent BioSolutions Inc (EBS) Q4 2024 Earnings Call Highlights: Strategic Advancements Amid ...

GuruFocus.com
·
04 Mar